Bangqi Biotech Closes RMB Tens of Millions Series A+ Financing
China Suzhou-based Bangqi Biotech closes RMB tens of millions Series A+ financing led by QF Capital and previous investor Step Holdings Fund.
The funds will be used primarily to commercialise the fully automated immunoblot analyser BQ-BM100 and to advance the registration of the multiplexed liquid phase immunofluorescence platform.
Bangqi Biotech was founded by Rui Tao in July 2020 and raised tens of millions of RMB in Series A funding in June 2022, led by Honest Capital and followed by Step Holdings Fund.
The post is available in: English – 简体中文
English (UK) 
Deutsch 
简体中文 
Français 
日本語 
Español 
Português 
Nederlands 
Polski 
Italiano 
한국어 
Русский 
